Review
REVISTA MEDICA DE CHILE  (2008)

Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs

Quiñones, L; Rosero, M; Roco A.; Moreno I.; Sasso, J.; Varela N.; Caceres D.; Saavedra I.

Keywords: in-vitro, cells, pharmacokinetics, healthy-subjects, polymorphisms, breast-cancer risk, pharmacogenetics, polymorphism, genetic, imatinib mesylate, antineoplastic drugs, cytochrome p450 enzyme system, human hepatocytes, anticancer drugs